Gastroenterologist: Amar Naik, MD | Loyola Medicine

Amar Naik, MD

Medicine

Gastroenterology
Assistant Professor
Director, IBD Program

Languages Spoken

English, Gujarati

Clinical Expertise

  • Inflammatory Bowel Disease (IBD)

About Dr. Naik

Interests
Sports, Family/Friends, Patient Education, Exercise

Medical Education

Medical School
University of Illinois College of Medicine, Chicago
Residency
Medical College of Wisconsin - Internal Medicine
Fellowship
  • Medical College of Wisconsin - Gastroenterology & Hepatology

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine Subspecialty Gastroenterology

Research

  • Endoscopic suturing of esophageal stent into skin flap after laryngectomy. Gupta, N; Verma, G; Venu, M; Naik, A; Shastri, N, VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy
  • Use of adenosine triphosphate to audit reprocessing of flexible endoscopes with an elevator mechanism. Quan, E; Mahmood, R; Naik, A; Sargon, P; Shastri, N; Venu, M; Parada, JP; Gupta, N, American Journal of Infection Control
  • Hematuria and Diarrhea: A Case Report. Groom, ML; Turin, A; Naik, AS, Gastroenterology
View All ResearchShow Less
  • Dyssynergic defecation: a treatable cause of persistent symptoms when inflammatory bowel disease is in remission Perera, L. P.; Ananthakrishnan, A. N.; Guilday, C.; Remshak, K.; Zadvornova, Y.; Naik, A. S.; Stein, D. J.; Massey, B. T., Digestive diseases and sciences
  • Surgical outcomes in the elderly with inflammatory bowel disease are similar to those in the younger population Bautista, M. C.; Otterson, M. F.; Zadvornova, Y.; Naik, A. S.; Stein, D. J.; Venu, N.; Perera, L. P., Digestive diseases and sciences
  • Impact of pregnancy on health-related quality of life of patients with inflammatory bowel disease Ananthakrishnan, A. N.; Zadvornova, Y.; Naik, A. S.; Issa, M.; Perera, L. P., Journal of digestive diseases
  • QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States Qumseya, B. J.; Ananthakrishnan, A. N.; Skaros, S.; Bonner, M.; Issa, M.; Zadvornova, Y.; Naik, A.; Perera, L.; Binion, D. G., Inflammatory bowel diseases
  • Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life Ulitsky, A.; Ananthakrishnan, A. N.; Naik, A.; Skaros, S.; Zadvornova, Y.; Binion, D. G.; Issa, M., JPEN.Journal of parenteral and enteral nutrition
  • Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease? Ananthakrishnan, A. N.; Beaulieu, D. B.; Ulitsky, A.; Zadvornova, Y.; Skaros, S.; Johnson, K.; Naik, A.; Perera, L.; Issa, M.; Binion, D. G.; Saeian, K., Inflammatory bowel diseases

Publications:
Ulitsky A, Ananthakrishnan AN, Naik AS, Skaros S, Zadvornova Y, Binion DG, Issa M. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011 May; 35 (3): 308-16

Qumseya BJ, Ananthakrishnan AN, Skaros S, Bonner M, Issa M, Zadvornova, Naik A, Perera L, Binion DG. QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States. Inflamm Bowel Dis. 2011 Jan; 17(1):77-83.

Naik, AS, Venu N. Nutritional Care in Adult Inflammatory Bowel Disease. Practical Gastro. 2012 June

Ananthakrishnan AN, Zadvornova Y, Naik AS, Issa M, Perera LP. Impact of pregnancy on health-related quality of life of patients with inflammatory bowel disease. J Dig Dis 2012 Sep; 13(9): 472-7.

Ananthakrishnan AN, Beaulieu DB, Ulitsky A, Zadvornova Y, Skaros S, Johnson K, Naik A, Perera L, Issa M, Binion DG, Saeian, K. Inflamm Bowel Dis. 2010 Mar; 16(3): 494-500.

Bautista MC, Otterson MF, Zadvornova Y, Naik AS, Stein DJ, Venu N, Perera LP. Surgical Outcomes in the Elderly with Inflammatory Bowel Disease are Similar to Those in the Younger Population. Dig Dis Sci. 2013 Jul 9.

Abstracts:
1. Naik A, Weber L, Knox J, Emmons J, Skaros S, Issa M, Binion D. “Long-term methotrexate maintenance immunomodulator therapy in ulcerative colitis.” Digestive Disease Week Washington DC May 2007.
2. Naik A, Qumseya B, Ananthakrishnan A, Zadvornova Y, Skaros S, Beaulieu D, Johnson K, Perera L, Binion D, Issa M. Anti-TNF therapy for Crohn’s Disease: Predictors of dose escalation and early discontinuation by 1 year of therapy. Gastroenterology 2009; 136 (Suppl 1): W1102.
3. Qumseya B, Naik A, Ananthakrishnan A, Zadvornova Y, Skaros S, Johnson K, Perera L, Binion D, Issa M. Increased BMI is not associated with dose escalation and failure of adalimumab therapy in Crohn’s Disease. Gastroenterology 2009; 136 (Suppl 1): 1106.
4. Beaulieu D, Ananthakrishnan A, Zadvornova Y, Stein D, Skaros S, Johnson K, Antonik S, Mepani R, Naik A, Binion D, Perera L. Seasonal variation in HRQoL and disease activity in patients with Inflammatory Bowel Disease: A Tertiary Care Center Experience. Gastroenterology 2009; 136 (Suppl 1): M1158.
5. Beaulieu D, Ananthakrishnan A, Zadvornova Y, Stein D, Mepani R, Antonik S, Skaros S, Johnson K, Naik A, Perera L, Binion D. Does duration of disease impact health related quality of life (HRQoL) in Inflammatory Bowel Disease? Gastroenterology 2009; 136 (Suppl 1): M1156.
6. Venu M, Naik A, Ananthakrishnan A, Zadvornova Y, Skaros S, Johnson K, Perera L, Binion D, Issa M. Early infliximab infusion in hospitalized severe UC patients: One year outcome. Gastroenterology 2009; 136 (Suppl 1): S152.
7. Chiplunker A, Ananthakrishnan A, Beaulieu D, Naik A, Zadvornova Y, Skaros S, Johnson K, Perera L, Binion D, Issa M. Long-term impact of Clostridium difficile on Inflammatory Bowel Disease. Gastroenterology 2009; 136 (Suppl 1): S1145.
8. Ananthakrishnan A, Beaulieu D, Issa M, Naik A, Zadvornova Y, Skaros S, Johnson K, Perera L, Binion D, Saeian K. Does primary sclerosing cholangitis impact quality of life in patients with Inflammatory Bowel Disease? Gastroenterology 2009; 136 (Suppl 1): S1160.
9. Venu M, Naik A, Ananthakrishnan A, Zadvornova Y, Skaros S, Johnson K, Perera L, Binion D, Issa M. Early Infliximab Infusion in Hospitalized Severe UC Patients: One Year Outcome. Gastroenterology 2009; 136(5). Supplement 1, Page A-201.
10. Naik A, Qumseya B, Ananthakrishnan A, Zadvornova Y, Skaros S, Beaulieu D, Johnson K, Perera L, Binion D, Issa M. Anti-TNF therapy for Crohn’s Disease: Predictors of dose escalation and early discontinuation by 1 year of therapy. Gastroenterology 2009; 136 (5). Supplement 1, Page A-654.
11. Chiplunker A, Ananthakrishnan A, Beaulieu D, Naik A, Zadvornova Y, Skaros S, Johnson K, Perera L, Binion D, Issa M. Long-term impact of Clostridium Difficile on Inflammatory Bowel Disease. Gastroenterology 2009; 136 (5). Supplement 1, Page A-199.
12. Ananthakrishnan AN, Beaulieu D, Naik AS, Zadvornova Y, Skaros S, Johnson K, Perera LP, Issa M, Binion DG, Saeian K. Does Primary Sclerosing Cholangitis Impact Quality of Life in Patients with Inflammatory Bowel Disease? Gastroenterology 2009; 136 (Suppl 1):S1160.
13. Naik A, Ananthakrishnan A, Zadvornova Y, Skaros S, Johnson K, Issa M. “Low Vitamin B12 and Vitamin D levels: association with lower bone density in Crohn’s disease population.”Presented as a Poster at Clinical Nutrition Week (American Society of Parenteral and Enteral Nutrition) New Orleans, LA, February 2009.
14. Zadvornova Y, Ananthakrishnan AN, Stein D, Skaros S, Johnson K, Naik AS, Perera LP, Issa M. Infliximab Monotherapy vs. Combined Infliximab-immunomodulator Therapy in Ulcerative Colitis. Gastroenterology 2010; 138(5), Supplement 1, Page S-690.
15. Venu M, Naik AS, Ananthakrishnan AN, Zadvornov